Literature DB >> 14645522

Transcriptional activation of the cyclin A gene by the architectural transcription factor HMGA2.

Michela A Tessari1, Monica Gostissa, Sandro Altamura, Riccardo Sgarra, Alessandra Rustighi, Clio Salvagno, Giuseppina Caretti, Carol Imbriano, Roberto Mantovani, Giannino Del Sal, Vincenzo Giancotti, Guidalberto Manfioletti.   

Abstract

The HMGA2 protein belongs to the HMGA family of architectural transcription factors, which play an important role in chromatin organization. HMGA proteins are overexpressed in several experimental and human tumors and have been implicated in the process of neoplastic transformation. Hmga2 knockout results in the pygmy phenotype in mice and in a decreased growth rate of embryonic fibroblasts, thus indicating a role for HMGA2 in cell proliferation. Here we show that HMGA2 associates with the E1A-regulated transcriptional repressor p120(E4F), interfering with p120(E4F) binding to the cyclin A promoter. Ectopic expression of HMGA2 results in the activation of the cyclin A promoter and induction of the endogenous cyclin A gene. In addition, chromatin immunoprecipitation experiments show that HMGA2 associates with the cyclin A promoter only when the gene is transcriptionally activated. These data identify the cyclin A gene as a cellular target for HMGA2 and, for the first time, suggest a mechanism for HMGA2-dependent cell cycle regulation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14645522      PMCID: PMC309667          DOI: 10.1128/MCB.23.24.9104-9116.2003

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  55 in total

1.  pRB binds to and modulates the transrepressing activity of the E1A-regulated transcription factor p120E4F.

Authors:  L Fajas; C Paul; O Zugasti; L Le Cam; J Polanowska; E Fabbrizio; R Medema; M L Vignais; C Sardet
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

2.  Target gene specificity of E2F and pocket protein family members in living cells.

Authors:  J Wells; K E Boyd; C J Fry; S M Bartley; P J Farnham
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

3.  Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells.

Authors:  R Reeves; D D Edberg; Y Li
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

4.  HMG-I/Y, a new c-Myc target gene and potential oncogene.

Authors:  L J Wood; M Mukherjee; C E Dolde; Y Xu; J F Maher; T E Bunton; J B Williams; L M Resar
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

Review 5.  Cyclin A2 transcriptional regulation: modulation of cell cycle control at the G1/S transition by peripheral cues.

Authors:  J M Blanchard
Journal:  Biochem Pharmacol       Date:  2000-10-15       Impact factor: 5.858

6.  The oncogenic properties of the HMG-I gene family.

Authors:  L J Wood; J F Maher; T E Bunton; L M Resar
Journal:  Cancer Res       Date:  2000-08-01       Impact factor: 12.701

7.  The expression of a truncated HMGI-C gene induces gigantism associated with lipomatosis.

Authors:  S Battista; V Fidanza; M Fedele; A J Klein-Szanto; E Outwater; H Brunner; M Santoro; C M Croce; A Fusco
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

8.  Cyclin A is a mediator of p120E4F-dependent cell cycle arrest in G1.

Authors:  L Fajas; C Paul; A Vié; S Estrach; R Medema; J M Blanchard; C Sardet; M L Vignais
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

9.  Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C.

Authors:  X Zhou; K F Benson; H R Ashar; K Chada
Journal:  Nature       Date:  1995-08-31       Impact factor: 49.962

10.  Transgenic mice expressing a truncated form of the high mobility group I-C protein develop adiposity and an abnormally high prevalence of lipomas.

Authors:  P Arlotta; A K Tai; G Manfioletti; C Clifford; G Jay; S J Ono
Journal:  J Biol Chem       Date:  2000-05-12       Impact factor: 5.157

View more
  51 in total

Review 1.  New tricks from an old oncogene: gene fusion and copy number alterations of MYB in human cancer.

Authors:  Göran Stenman; Mattias K Andersson; Ywonne Andrén
Journal:  Cell Cycle       Date:  2010-08-28       Impact factor: 4.534

2.  Molecular basis of clonal expansion of hematopoiesis in 2 patients with paroxysmal nocturnal hemoglobinuria (PNH).

Authors:  Norimitsu Inoue; Tomohisa Izui-Sarumaru; Yoshiko Murakami; Yuichi Endo; Jun-Ichi Nishimura; Ken Kurokawa; Maki Kuwayama; Hiroaki Shime; Takashi Machii; Yuzuru Kanakura; Gabrielle Meyers; Carl Wittwer; Zhong Chen; William Babcock; Debra Frei-Lahr; Charles J Parker; Taroh Kinoshita
Journal:  Blood       Date:  2006-08-29       Impact factor: 22.113

3.  Depletion of BRCA1 impairs differentiation but enhances proliferation of mammary epithelial cells.

Authors:  Saori Furuta; Xianzhi Jiang; Bingnan Gu; Eric Cheng; Phang-Lang Chen; Wen-Hwa Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-20       Impact factor: 11.205

4.  JunB breakdown in mid-/late G2 is required for down-regulation of cyclin A2 levels and proper mitosis.

Authors:  Rosa Farràs; Véronique Baldin; Sandra Gallach; Claire Acquaviva; Guillaume Bossis; Isabelle Jariel-Encontre; Marc Piechaczyk
Journal:  Mol Cell Biol       Date:  2008-04-07       Impact factor: 4.272

5.  HMGA2 maintains oncogenic RAS-induced epithelial-mesenchymal transition in human pancreatic cancer cells.

Authors:  Sugiko Watanabe; Yasuaki Ueda; Shin-ichi Akaboshi; Yuko Hino; Yoko Sekita; Mitsuyoshi Nakao
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

6.  The High Mobility Group A proteins contribute to thyroid cell transformation by regulating miR-603 and miR-10b expression.

Authors:  Paula Mussnich; Daniela D'Angelo; Vincenza Leone; Carlo Maria Croce; Alfredo Fusco
Journal:  Mol Oncol       Date:  2013-01-17       Impact factor: 6.603

7.  E4F1-mediated control of pyruvate dehydrogenase activity is essential for skin homeostasis.

Authors:  Perrine Goguet-Rubio; Berfin Seyran; Laurie Gayte; Florence Bernex; Anne Sutter; Hélène Delpech; Laetitia Karine Linares; Romain Riscal; Cendrine Repond; Geneviève Rodier; Olivier Kirsh; Jawida Touhami; Jean Noel; Charles Vincent; Nelly Pirot; Guillaume Pavlovic; Yann Herault; Marc Sitbon; Luc Pellerin; Claude Sardet; Matthieu Lacroix; Laurent Le Cam
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-12       Impact factor: 11.205

8.  siRNA-Mediated Silencing of HMGA2 Induces Apoptosis and Cell Cycle Arrest in Human Colorectal Carcinoma.

Authors:  Sahar Esmailzadeh; Behzad Mansoori; Ali Mohammadi; Dariush Shanehbandi; Behzad Baradaran
Journal:  J Gastrointest Cancer       Date:  2017-06

9.  Identification of target genes for wild type and truncated HMGA2 in mesenchymal stem-like cells.

Authors:  Jørn Henriksen; Marianne Stabell; Leonardo A Meza-Zepeda; Silje Au Lauvrak; Moustapha Kassem; Ola Myklebost
Journal:  BMC Cancer       Date:  2010-06-25       Impact factor: 4.430

Review 10.  HMGA2 and high-grade serous ovarian carcinoma.

Authors:  Jingjing Wu; Jian-Jun Wei
Journal:  J Mol Med (Berl)       Date:  2013-05-19       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.